GIBELLINI, Davide
 Distribuzione geografica
Continente #
NA - Nord America 2.842
EU - Europa 2.680
AS - Asia 1.256
AF - Africa 119
SA - Sud America 6
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.910
Nazione #
US - Stati Uniti d'America 2.817
CN - Cina 884
GB - Regno Unito 585
IT - Italia 429
IE - Irlanda 395
RU - Federazione Russa 352
FR - Francia 261
SG - Singapore 250
SE - Svezia 200
DE - Germania 181
FI - Finlandia 148
TG - Togo 113
UA - Ucraina 47
VN - Vietnam 33
JP - Giappone 24
CA - Canada 22
NL - Olanda 22
BE - Belgio 21
TR - Turchia 21
HK - Hong Kong 13
KR - Corea 10
CZ - Repubblica Ceca 8
ES - Italia 8
IN - India 8
AZ - Azerbaigian 4
BG - Bulgaria 4
AU - Australia 3
CL - Cile 3
EU - Europa 3
AT - Austria 2
BD - Bangladesh 2
BR - Brasile 2
HU - Ungheria 2
IL - Israele 2
IR - Iran 2
MA - Marocco 2
MX - Messico 2
PK - Pakistan 2
PL - Polonia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
ZA - Sudafrica 2
AL - Albania 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
IS - Islanda 1
KE - Kenya 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RO - Romania 1
Totale 6.910
Città #
Southend 527
Chandler 497
Dublin 389
Ashburn 356
Beijing 259
Woodbridge 238
Verona 190
Jacksonville 184
Ann Arbor 178
Singapore 158
Lomé 113
Lawrence 95
Princeton 95
Houston 92
Wilmington 83
Washington 71
New York 64
Redmond 58
Jinan 52
Helsinki 51
Shenyang 49
Boardman 47
Nanjing 45
Seattle 40
Dallas 39
Sindelfingen 39
Lancaster 36
Haikou 24
Tianjin 24
Tokyo 22
Brussels 21
Hebei 21
Dong Ket 20
Guangzhou 20
Hangzhou 19
Milan 18
Redwood City 18
Toronto 18
Munich 17
Taizhou 17
Bologna 16
Fuzhou 13
Nanchang 13
Norwalk 13
Amsterdam 12
Lanzhou 12
Ningbo 12
San Francisco 12
Bussolengo 10
Changsha 10
Chicago 10
Lappeenranta 10
Los Angeles 10
Sant'Ambrogio di Valpolicella 10
Seoul 10
Chions 9
Falls Church 9
Hong Kong 9
Taiyuan 8
Brno 7
Jiaxing 7
Fairfield 6
Rome 6
Zhengzhou 6
Isola della Scala 5
San Giovanni Lupatoto 5
Treviso 5
Baku 4
Boydton 4
Dongguan 4
Frankfurt am Main 4
Kent 4
Scandiano 4
Buffalo 3
Campo di Carne 3
Clearwater 3
Detroit 3
Rieti 3
Roverbella 3
San Pietro di Morubio 3
Santa Clara 3
Trieste 3
Udine 3
Arzignano 2
Asotthalom 2
Atri 2
Barcelona 2
Cambridge 2
Catania 2
Central 2
Columbus 2
Cox 2
Dhaka 2
Esslingen am Neckar 2
Groningen 2
Hyderabad 2
Kochi 2
London 2
Madrid 2
Mannheim 2
Totale 4.647
Nome #
Guidelines for the qualitative detection of viral genomes in dried blood spots. 112
Dolutegravir Monotherapy in HIV-Infected Naive Patients With <100,000 Copies/mL HIV RNA Load 109
HIV-1 Env associates with HLA-C free-chains at the cell membrane modulating viral infectivity 108
Active surveillance for early detection of SARS-CoV-2 infections across high-risk community key populations. 97
Atazanavir/ritonavir monotherapy: 96 week efficacy, safety and bone mineral density from the MODAt randomized trial 96
Development of a real-time quantitative polymerase chain reaction assay for the detection of congenital human cytomegalovirus infection in urine samples 95
IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia 93
Assessment of NS1 gene-specific real time quantitative TaqMan PCR for the detection of Human Bocavirus in respiratory samples 90
HIV-1-associated neurocognitive disorders: is HLA-C binding stability to β2-microglobulin a missing piece of the pathogenetic puzzle? 88
Deciphering the state of immune silence in fatal COVID-19 patients 84
Stability and expression levels of HLA-C on the cell membrane modulate HIV-1 infectivity 83
Dolutegravir monotherapy in HIV-infected naive patients with an HIV-RNA load <100 000 copies/mL: a medium-term follow-up 78
Detection of serum antibodies to human intracisternal A-type retroviral particles in chronic idiopathic urticaria 77
Human T-cell Leukemia virus type II increase telomerase activity in uninfected CD34+ hematopoietic progenitor cells 76
Analysis of the effects of specific protease inhibitors on OPG/RANKL regulation in an osteoblast-like cell line 76
Correction for Parolini et al., "Stability and Expression Levels of HLA-C on the Cell Membrane Modulate HIV-1 Infectivity" 75
'High' antiretroviral deintensification strategy and cellular HIV DNA levels 75
M48U1 and Tenofovir combination synergistically inhibits HIV infection in activated PBMCs and human cervicovaginal histocultures 74
HLA-C and HIV-1: a matter of stability 73
Dynamics of SARS-CoV2 Infection and Multi-Drug Resistant Bacteria Superinfection in Patients With Assisted Mechanical Ventilation 72
Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir 69
Duplex real-time polymerase chain reaction assay for the detection of human KIPyV and WUPyV in nasopharyngeal aspirate pediatric samples 68
SARS-CoV-2 infection in health workers: analysis from Verona SIEROEPID Study during the pre-vaccination era 68
COVID-19 seroprevalence amongst healthcare workers: potential biases in estimating infection prevalence 68
A novel stop codon mutation within the hepatitis B surface gene is detected in the liver but not in the peripheral blood mononuclear cells of HIV-infected individuals with occult HBV infection. 67
The immune modulatory effects of umbilical cord-derived mesenchymal stromal cells in severe COVID-19 pneumonia 66
Antiretroviral molecules and cardiovascular diseases. 65
Post-Vaccination SARS-CoV-2 Infections among Health Workers at the University Hospital of Verona, Italy: A Retrospective Cohort Survey 65
Analysis of the effects of HIV-1 Tat on the survival and differentiation of vessel wall-derived mesenchymal stem cells. 64
Prevalence of sub-clinical vertebral fractures in HIV-infected patients. 64
Pro-inflammatory effects of palytoxin: an in vitro study on human keratinocytes and inflammatory cells 64
HIV-1 gp120 impairs the differentiation and survival of cord blood CD34+ HPCs induced to the erythroid lineage 63
Durable viral suppression in an HIV-infected patient in the absence of antiretroviral therapy 62
Calcaneal quantitative ultrasound (QUS) and dual X-ray absorptiometry (DXA) bone analysis in adult HIV-positive patients 61
Determinants of Persistence of Symptoms and Impact on Physical and Mental Wellbeing in Long COVID: A Prospective Cohort Study 61
Unveiling Another Missing Piece in EBV-Driven Lymphomagenesis: EBV-Encoded MicroRNAs Expression in EBER-Negative Burkitt Lymphoma Cases 60
Interferon gamma inducible protein 16 (IFI16) expression is reduced in mantle cell lymphoma 60
Assessment of SARS-CoV-2 IgG and IgM antibody detection with a lateral flow immunoassay test 59
Effects of Antiretroviral Molecules on Survival and Gene Expression of An Osteoblast-like Cell Line 58
HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells. 57
HIV-1 and HCV detection in dried blood spots by SYBR Green multiplex real-time RT-PCR 57
Molecular bases of osteoporosis in HIV: the role of the virus and antiretroviral therapy 57
Risk and severity of SARS-CoV-2 infection in breast cancer patients undergoing a structured infection screening program at the University and Hospital Trust of Verona 56
Bone alterations during HIV infection. 55
CFTR Modulation Reduces SARS-CoV-2 Infection in Human Bronchial Epithelial Cells 53
Impact of different antiretroviral strategies on total HIV-DNA level in virologically suppressed HIV-1 infected patients 52
Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified. 51
The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma. 51
Metabolic bone disease in HIV infection 51
Cross-immunization against respiratory coronaviruses may protect children from SARS-CoV2: more than a simple hypothesis? 51
HIV-1 subtype C transmission network: the phylogenetic reconstruction strongly supports the epidemiological data 50
Diagnostic Accuracy of a Rapid SARS-CoV-2 Antigen Test Among People Experiencing Homelessness: A Prospective Cohort and Implementation Study 49
Persistent chemosensory dysfunction in a young patient with mild COVID-19 with partial recovery 15 months after the onset 49
Peptide-derivatized SB105-A10 dendrimer inhibits the infectivity of R5 and X4 HIV-1 strains in primary PBMCs and cervicovaginal histocultures. 48
HIV-1 DNA proviral load in treated and untreated HIV-1 seropositive patients 48
The traditional use of Vachellia nilotica for sexually transmitted diseases is substantiated by the antiviral activity of its bark extract against sexually transmitted viruses 48
Preliminary Study on the Possibility to Detect Virus Nucleic Acids in Post-Mortem Blood Samples 47
HIV-1 coreceptor usage in paired plasma RNA and proviral DNA from patients with acute and chronic infection never treated with antiretroviral therapy. 47
Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages. 47
HIV-1 infection of a nurse from a newborn with an unknown HIV infection: A case report 47
Incomplete IgG response to HIV-1 proteins and low avidity levels in recently converted HIV patients treated with early antiretroviral therapy 47
Characteristics and Outcomes of Bloodstream Infections in a Tertiary-Care Pediatric Hematology–Oncology Unit: A 10-Year Study 47
Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern 46
Oxidative stress induced by palytoxin in human keratinocytes is mediated by a H+-dependent mitochondrial pathway. 45
Recent and long-lasting infections: the need for avidity testing in HIV-1 infected subjects. 44
Prospective evaluation of bone markers, parathormone and 1,25-(OH)2 vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz. 44
Thermosensitive and mucoadhesive pluronic®/hydroxypropylmethylcellulose hydrogel containing the mini CD4 M48U1 is a promising efficient barrier against HIV diffusion through macaque cervico-vaginal mucus 44
COVID-19 Vaccine: Between Myth and Truth 44
Prevalence of and short-term changes in conjunctival manifestations among patients with SARS-CoV-2 infection 44
Usefulness and Limitations of Anti-S IgG Assay in Detecting Previous SARS-CoV-2 Breakthrough Infection in Fully Vaccinated Healthcare Workers 43
Sustained autocrine induction and impaired negative feedback of osteoclastogenesis in CD14(+) cells of giant cell tumor of bone. 42
Ultrastructural Characterization of Human Bronchial Epithelial Cells during SARS-CoV-2 Infection: Morphological Comparison of Wild-Type and CFTR-Modified Cells 40
SARS-CoV-2 and Its Variants in Thrice-Infected Health Workers: A Case Series from an Italian University Hospital 40
Prevalence of R5 strains in multi-treated HIV subjects and impact of new regimens including maraviroc in a selected group of patients with CCR5-tropic HIV-1 infection. 40
HIV-1 Tat protein enhances RANKL/M-CSF-mediated osteoclast differentiation 40
Human T-lymphotropic virus type 1 (HTLV-1) prevalence and quantitative detection of DNA proviral load in individuals with indeterminate/positive serological results. 40
IFI16 Expression Is Related to Selected Transcription Factors during B-Cell Differentiation 39
HIV-related mechanisms in atherosclerosis and cardiovascular diseases. 38
Virus-encoded microRNA contributes to the molecular profile of EBV-positive burkitt lymphomas 38
Dendritic cell function in cytomegalovirus-infected patients with mononucleosis. 37
Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway. 36
Editorial: Molecular Mechanisms of Pathogen-Driven Infectious and Neoplastic Diseases 36
Development of drug resistance in HIV-1 patients receiving a combination of stavudine, lamivudine and efavirenz 35
SARS-CoV-2 Breakthrough Infections: Incidence and Risk Factors in a Large EuropeanMulticentric Cohort of HealthWorkers 35
HIV-1 tat protein and cell proliferation and survival: a brief review. 34
Transiently transfected and stably integrated HIV-1 LTR responds differentially to the silencing activity of the Kruppel-associated box (KRAB) transcriptional repressor domain 33
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition. 33
First and second waves of SARS-COV-2 infection in the obstetric population 32
HIV-1 negatively affects the survival/maturation of cord blood CD34(+) hematopoietic progenitor cells differentiated towards megakaryocytic lineage by HIV-1 gp120/CD4 membrane interaction 32
Overexpression of MLH-1 and psoriasin genes in cutaneous angiofibromas from tuberous sclerosis complex patients. 32
Antimicrobial susceptibility of anaerobic clinical isolates: A two-year surveillance 31
Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus 31
Simultaneous detection of HCV and HIV-1 by SYBR Green real time multiplex RT-PCR technique in plasma samples. 31
Impaired dendritic cell immunophenotype and function in heart transplant patients undergoing active cytomegalovirus infection. 30
Gene expression profile predicts response to the combination of tosedostat and low-dose cytarabine in elderly AML. 30
CFTR Inhibitors Display In Vitro Antiviral Activity against SARS-CoV-2 29
Quantitative DNA proviral detection in HIV-1 patients treated with antiretroviral therapy 28
HIV-1 DNA load analysis in peripheral blood lymphocytes and monocytes from naïve and HAART-treated individuals. 28
Different patterns of HIV-1 DNA after therapy discontinuation. 28
Determinants of anti-S immune response at 6 months after COVID-19 vaccination in a multicentric European cohort of healthcare workers - ORCHESTRA project 27
Totale 5.487
Categoria #
all - tutte 36.458
article - articoli 35.460
book - libri 0
conference - conferenze 602
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 396
Totale 72.916


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020360 0 0 0 4 62 51 10 5 10 68 90 60
2020/2021505 37 91 45 48 72 67 13 5 21 14 48 44
2021/2022830 27 157 19 81 24 18 8 90 71 56 66 213
2022/20231.889 107 126 127 312 265 570 15 85 193 18 39 32
2023/20241.509 36 100 177 105 178 390 113 85 6 29 183 107
2024/2025802 263 212 233 94 0 0 0 0 0 0 0 0
Totale 7.183